IBDEI15D ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41703,0)
 ;;=90471^^158^2046^1^^^^1
 ;;^UTILITY(U,$J,358.3,41703,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41703,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,41703,1,3,0)
 ;;=3^ADMIN IMMUNIZATION,SINGLE
 ;;^UTILITY(U,$J,358.3,41704,0)
 ;;=90472^^158^2046^2^^^^1
 ;;^UTILITY(U,$J,358.3,41704,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41704,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,41704,1,3,0)
 ;;=3^ADMIN IMMUNIZATION,EA ADDL
 ;;^UTILITY(U,$J,358.3,41705,0)
 ;;=99395^^158^2047^1^^^^1
 ;;^UTILITY(U,$J,358.3,41705,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41705,1,2,0)
 ;;=2^99395
 ;;^UTILITY(U,$J,358.3,41705,1,3,0)
 ;;=3^PREVENTIVE MED,EST PT 18-39
 ;;^UTILITY(U,$J,358.3,41706,0)
 ;;=99396^^158^2047^2^^^^1
 ;;^UTILITY(U,$J,358.3,41706,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41706,1,2,0)
 ;;=2^99396
 ;;^UTILITY(U,$J,358.3,41706,1,3,0)
 ;;=3^PREVENTIVE MED,EST PT 40-64
 ;;^UTILITY(U,$J,358.3,41707,0)
 ;;=99397^^158^2047^3^^^^1
 ;;^UTILITY(U,$J,358.3,41707,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41707,1,2,0)
 ;;=2^99397
 ;;^UTILITY(U,$J,358.3,41707,1,3,0)
 ;;=3^PREVENTIVE MED,EST PT > 64
 ;;^UTILITY(U,$J,358.3,41708,0)
 ;;=99385^^158^2048^1^^^^1
 ;;^UTILITY(U,$J,358.3,41708,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41708,1,2,0)
 ;;=2^99385
 ;;^UTILITY(U,$J,358.3,41708,1,3,0)
 ;;=3^PREVENTIVE MED,NEW PT 18-39
 ;;^UTILITY(U,$J,358.3,41709,0)
 ;;=99386^^158^2048^2^^^^1
 ;;^UTILITY(U,$J,358.3,41709,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41709,1,2,0)
 ;;=2^99386
 ;;^UTILITY(U,$J,358.3,41709,1,3,0)
 ;;=3^PREVENTIVE MED,NEW PT 40-64
 ;;^UTILITY(U,$J,358.3,41710,0)
 ;;=99387^^158^2048^3^^^^1
 ;;^UTILITY(U,$J,358.3,41710,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41710,1,2,0)
 ;;=2^99387
 ;;^UTILITY(U,$J,358.3,41710,1,3,0)
 ;;=3^PREVENTIVE MED,NEW PT > 64
 ;;^UTILITY(U,$J,358.3,41711,0)
 ;;=N20.0^^159^2049^1
 ;;^UTILITY(U,$J,358.3,41711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41711,1,3,0)
 ;;=3^Calculus of Kidney
 ;;^UTILITY(U,$J,358.3,41711,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,41711,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,41712,0)
 ;;=N28.9^^159^2049^9
 ;;^UTILITY(U,$J,358.3,41712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41712,1,3,0)
 ;;=3^Kidney & Ureter Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,41712,1,4,0)
 ;;=4^N28.9
 ;;^UTILITY(U,$J,358.3,41712,2)
 ;;=^5015630
 ;;^UTILITY(U,$J,358.3,41713,0)
 ;;=N39.0^^159^2049^10
 ;;^UTILITY(U,$J,358.3,41713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41713,1,3,0)
 ;;=3^UTI,Site Unspec
 ;;^UTILITY(U,$J,358.3,41713,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,41713,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,41714,0)
 ;;=R31.9^^159^2049^5
 ;;^UTILITY(U,$J,358.3,41714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41714,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,41714,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,41714,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,41715,0)
 ;;=R31.0^^159^2049^3
 ;;^UTILITY(U,$J,358.3,41715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41715,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,41715,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,41715,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,41716,0)
 ;;=R31.1^^159^2049^2
 ;;^UTILITY(U,$J,358.3,41716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41716,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,41716,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,41716,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,41717,0)
 ;;=R31.2^^159^2049^4
 ;;^UTILITY(U,$J,358.3,41717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41717,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,41717,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,41717,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,41718,0)
 ;;=N39.3^^159^2049^7
 ;;^UTILITY(U,$J,358.3,41718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41718,1,3,0)
 ;;=3^Incontinence,Stress
 ;;^UTILITY(U,$J,358.3,41718,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,41718,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,41719,0)
 ;;=N39.41^^159^2049^8
 ;;^UTILITY(U,$J,358.3,41719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41719,1,3,0)
 ;;=3^Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,41719,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,41719,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,41720,0)
 ;;=N39.46^^159^2049^6
 ;;^UTILITY(U,$J,358.3,41720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41720,1,3,0)
 ;;=3^Incontinence,Mixed
 ;;^UTILITY(U,$J,358.3,41720,1,4,0)
 ;;=4^N39.46
 ;;^UTILITY(U,$J,358.3,41720,2)
 ;;=^5015685
 ;;^UTILITY(U,$J,358.3,41721,0)
 ;;=A63.0^^159^2050^17
 ;;^UTILITY(U,$J,358.3,41721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41721,1,3,0)
 ;;=3^Anogenital Warts,Venereal
 ;;^UTILITY(U,$J,358.3,41721,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,41721,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,41722,0)
 ;;=A56.02^^159^2050^32
 ;;^UTILITY(U,$J,358.3,41722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41722,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,41722,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,41722,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,41723,0)
 ;;=B37.3^^159^2050^23
 ;;^UTILITY(U,$J,358.3,41723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41723,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,41723,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,41723,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,41724,0)
 ;;=A59.01^^159^2050^104
 ;;^UTILITY(U,$J,358.3,41724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41724,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,41724,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,41724,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,41725,0)
 ;;=D06.9^^159^2050^24
 ;;^UTILITY(U,$J,358.3,41725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41725,1,3,0)
 ;;=3^Carcinoma in Situ,Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,41725,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,41725,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,41726,0)
 ;;=D06.0^^159^2050^25
 ;;^UTILITY(U,$J,358.3,41726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41726,1,3,0)
 ;;=3^Carcinoma in Situ,Endocervix
 ;;^UTILITY(U,$J,358.3,41726,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,41726,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,41727,0)
 ;;=D06.1^^159^2050^26
 ;;^UTILITY(U,$J,358.3,41727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41727,1,3,0)
 ;;=3^Carcinoma in Situ,Exocervix
 ;;^UTILITY(U,$J,358.3,41727,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,41727,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,41728,0)
 ;;=N60.11^^159^2050^41
 ;;^UTILITY(U,$J,358.3,41728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41728,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Right Breast
 ;;^UTILITY(U,$J,358.3,41728,1,4,0)
 ;;=4^N60.11
 ;;^UTILITY(U,$J,358.3,41728,2)
 ;;=^5015773
 ;;^UTILITY(U,$J,358.3,41729,0)
 ;;=N60.12^^159^2050^40
 ;;^UTILITY(U,$J,358.3,41729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41729,1,3,0)
 ;;=3^Diffuse Cystic Mastopathy,Left Breast
 ;;^UTILITY(U,$J,358.3,41729,1,4,0)
 ;;=4^N60.12
 ;;^UTILITY(U,$J,358.3,41729,2)
 ;;=^5015774
 ;;^UTILITY(U,$J,358.3,41730,0)
 ;;=N63.^^159^2050^74
 ;;^UTILITY(U,$J,358.3,41730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41730,1,3,0)
 ;;=3^Lump in Breast,Unspec
 ;;^UTILITY(U,$J,358.3,41730,1,4,0)
 ;;=4^N63.
 ;;^UTILITY(U,$J,358.3,41730,2)
 ;;=^5015791
 ;;^UTILITY(U,$J,358.3,41731,0)
 ;;=N73.9^^159^2050^57
 ;;^UTILITY(U,$J,358.3,41731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41731,1,3,0)
 ;;=3^Female Pelvic Inflamm Dis,Unspec
 ;;^UTILITY(U,$J,358.3,41731,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,41731,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,41732,0)
 ;;=N72.^^159^2050^65
 ;;^UTILITY(U,$J,358.3,41732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41732,1,3,0)
 ;;=3^Inflammatory Disease of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,41732,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,41732,2)
 ;;=^5015812
